🇺🇸 FDA
Patent

US 7335685

Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof

granted A61PA61P25/14A61P25/24

Quick answer

US patent 7335685 (Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P25/14, A61P25/24, A61P25/28